May 23, 2023, 13:04 PM by User Not Found

Bio-IT World | Bryn Roberts has spent thirty years in informatics and data, most recently at Roche and before that at AstraZeneca. Now as Global Head of Data and Analytics at Roche Information Solutions, Roberts applies his career-long learnings to the current era of data in life sciences.

May 19, 2023, 16:20 PM by User Not Found

Bio-IT World | Earlier this week during the Bio-IT World Conference & Expo, Bio-IT World named five 2023 Best of Show Awards winners including new products from Data Cicada, Genomenon, GitHub, Monomer Bio, and Starfish Storage.

May 19, 2023, 14:01 PM by

Expert.ai Platform for Life Sciences strengthens solutions and industry practice honed by expert.ai from real-world implementations with global organizations and scientific publishers such as Sanofi, New England Journal of Medicine, EBSCO, 3M Health, and INSERM. Our new Platform for Life Sciences has been chosen as a “Best of Show” finalist for 2023 Bio-IT Awards!

May 19, 2023, 14:01 PM by

May 19, 2023, 14:01 PM by

May 19, 2023, 14:00 PM by

May 19, 2023, 14:00 PM by

May 19, 2023, 14:00 PM by

Form Bio, the breakthrough computational life sciences platform, announced today that it has been selected to help organizations adopt Google Cloud’s Multiomics Suite, accelerating the research of life science companies and academic institutions. In addition, Form Bio has been designated by Google as a Google Cloud Premier partner.

May 19, 2023, 14:00 PM by

Global strategic advisory agency Inizio has announced two senior leadership appointments to its Inizio Medical division, strengthening the AI and innovation capabilities of the business.

May 19, 2023, 14:00 PM by

May 19, 2023, 14:00 PM by

May 19, 2023, 14:00 PM by

A consortium of international scientists has taken the first step toward incorporating quantum computing into AI-powered drug discovery.

May 19, 2023, 14:00 PM by

OmicsEdge has launched an industry leading drug discovery service that leverages Almaden’s g.nome™ platform to streamline the iteration process. The service makes it easy for labs to conduct a quick analysis of a patient or trial participant’s medical condition and genomics, gaining valuable insight in genomic criteria and how it affects elevated risk. It can be used to significantly accelerate the drug discovery process and eliminate trial-and-error with abilities such as identifying causal variants that make ideal drug targets.

May 19, 2023, 14:00 PM by

May 19, 2023, 14:00 PM by

May 18, 2023, 01:00 AM by User Not Found

Bio-IT World | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs.

May 16, 2023, 01:00 AM by User Not Found

Bio-IT World | Anatomical investigations performed on 45 individuals who donated their bodies to science have revealed that the human gut is stunningly diverse based on the size of the organs making up the gastrointestinal (GI) system. Whether those differences are based on what people eat, where they live, or their ancestry is anyone’s guess.

May 12, 2023, 16:29 PM by

Generative artificial intelligence (AI)-driven drug discovery company Insilico Medicine is offering a new, free online course on Disease Modeling and Target Identification. Designed for a broad audience that includes researchers, scientists, pharmaceutical professionals, and students, the course provides lessons from leading experts at Insilico, including biologists, application scientists, and bioinformaticians.

May 12, 2023, 14:51 PM by

Creative Biolabs is ready for the PEGS Boston Summit, which will exhibit at booth 205 from May 15–19.

May 12, 2023, 14:51 PM by

European Consulting and Safety Services Provider Adopts PubHive’s Validated Drug Safety and Pharmacovigilance Software Platform to Automate Literature Surveillance and Screening